心拍安定剤市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、エンドユーザー別、地域別、競争別、2020-2030F

心拍安定剤の世界市場は、2024年に2億6,428万米ドルと評価され、2030年には3億7,309万米ドルに達し、CAGR5.89％で成長すると予測されています。

同市場は、より広範な医療機器産業の中でもダイナミックで急速に発展しているセグメントです。心拍安定剤は、心臓安定装置または心臓位置決め装置とも呼ばれ、心肺バイパス（CPB）を必要とせずに拍動している心臓への処置を可能にする心臓手術に不可欠なツールです。市場は主に、心血管疾患の有病率の上昇、手術手技の進歩、高齢化人口の増加などの要因によって牽引されています。

心拍安定剤の世界市場を促進している主な要因は、冠動脈疾患や心臓弁膜症などの心血管疾患の発生率の増加です。心拍安定剤により、外科医は心臓の拍動を維持したまま手術を行うことができ、CPBに伴うリスクを軽減することができます。この手技は、回復時間の短縮や術後合併症の減少などの利点から、大きな支持を得ています。

技術革新が市場の成長をさらに後押ししています。心拍安定剤のデザインや素材の進歩により、機能性や使いやすさが向上しています。これらのデバイスは現在、機械式スタビライザー、吸引式スタビライザー、ロボット支援スタビライザーなどさまざまな形態で提供されており、外科医にさまざまな手術ニーズに対応する多様な選択肢を提供しています。

主な市場促進要因

心血管疾患の有病率の上昇：

主な市場課題

安全性と有効性への懸念

主な市場動向

低侵襲心臓手術（MICS）：

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の心拍安定剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（真空式安定剤、機械式安定剤、その他）
  • 用途別（冠動脈バイパス術（CABG）、先天性心疾患手術、心房細動手術、その他）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の心拍安定剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の心拍安定剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の心拍安定剤市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の心拍安定剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの心拍安定剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Terumo Cardiovascular Systems Corporation
• Medtronic PLC
• Visionary Medtech Solutions Pvt. Ltd.
• Getinge AB
• LivaNova PLC
• Guidant Corporation
• HTKD Medical.
• Chase Medical
• Edwards Lifesciences Corporation
• Atricure, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Beating Heart Stabilizers Market for Beating Heart Stabilizers was valued at USD 264.28 million in 2024 and is projected to reach USD 373.09 million by 2030, growing at a compound annual growth rate (CAGR) of 5.89%. This market is a dynamic and rapidly advancing segment within the broader medical device industry. Beating heart stabilizers, also referred to as cardiac stabilizers or cardiac positioning devices, are vital tools in cardiac surgery that enable procedures on a beating heart without the need for cardiopulmonary bypass (CPB). The market is primarily driven by factors such as the rising prevalence of cardiovascular diseases, advancements in surgical techniques, and the growing aging population.

A key factor propelling the global Beating Heart Stabilizers market is the increasing incidence of cardiovascular diseases, including coronary artery disease and valvular heart diseases. These conditions often require surgical intervention, and beating heart stabilizers allow surgeons to perform surgeries while the heart continues to beat, thereby reducing risks associated with CPB. This technique has gained significant traction due to its advantages, including shorter recovery times and fewer postoperative complications.

Technological innovations have further fueled the growth of the market. Advancements in the design and materials of beating heart stabilizers have enhanced their functionality and ease of use. These devices are now available in various forms, including mechanical stabilizers, suction-based stabilizers, and robotic-assisted stabilizers, offering surgeons a variety of options for different surgical needs.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases:

The global Beating Heart Stabilizers market is expanding due to the rising prevalence of chronic diseases, particularly cardiovascular conditions. Cardiovascular diseases (CVDs) are responsible for approximately 18 million deaths annually, highlighting the urgent need for effective surgical interventions. Beating heart stabilizers are critical for off-pump coronary artery bypass (OPCAB) surgeries, allowing surgeons to operate on a beating heart without cardiopulmonary bypass, which reduces complications and accelerates patient recovery. The increasing prevalence of CVDs, driven by aging populations and lifestyle changes, has intensified the demand for these stabilizers. Additionally, hypertension, a major risk factor for heart disease, affects around 1.3 billion people globally, with nearly half unaware of their condition, further emphasizing the need for advanced surgical solutions.

Key Market Challenges

Safety and Efficacy Concerns:

Beating heart stabilizers are complex, precision-engineered devices that require state-of-the-art technology and materials to ensure both safety and effectiveness. The high research and development costs associated with these devices often result in elevated prices, which can be a barrier for healthcare providers, particularly smaller hospitals or facilities in resource-limited regions. The high cost of beating heart stabilizers limits access to these advanced surgical tools, particularly in developing countries, and contributes to existing healthcare disparities. Patients in economically disadvantaged regions may have limited access to the latest treatment options, exacerbating inequalities in healthcare outcomes. Even in well-established healthcare systems, the acquisition of costly medical equipment can strain financial resources.

Key Market Trends

Minimally Invasive Cardiac Surgery (MICS):

Minimally invasive cardiac surgery has gained significant traction as a less invasive, patient-friendly alternative to traditional heart surgery. This trend is fueling the demand for beating heart stabilizers, as these devices are essential for performing complex procedures through smaller incisions. MICS offers patients benefits such as reduced postoperative pain, shorter hospital stays, and faster recovery times, making it a popular choice among both surgeons and patients. Beating heart stabilizers play a critical role in MICS by ensuring the stability and precision needed to operate on a beating heart, contributing to the success of these procedures. As healthcare continues to advance technologically, the demand for innovative tools like beating heart stabilizers is expected to grow, further solidifying their importance in modern cardiac surgery.

Key Market Players

• Terumo Cardiovascular Systems Corporation
• Medtronic PLC
• Visionary Medtech Solutions Pvt. Ltd.
• Getinge AB
• LivaNova PLC
• Guidant Corporation
• HTKD Medical.
• Chase Medical
• Edwards Lifesciences Corporation
• Atricure, Inc.

Report Scope:

In this report, the Global Beating Heart Stabilizers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Beating Heart Stabilizers Market, By Product Type:

• Vacuum based Stabilizers
• Mechanical Stabilizers
• Others

Beating Heart Stabilizers Market, By Application:

• Coronary Artery Bypass (CABG)
• Congenital Heart Defect Surgeries
• Atrial fibrillation surgery
• Others

Beating Heart Stabilizers Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centres
• Others

Beating Heart Stabilizers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Beating Heart Stabilizers Market.

Available Customizations:

Global Beating Heart Stabilizers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Beating Heart Stabilizers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Vacuum based Stabilizers, Mechanical Stabilizers, Others)
  • 5.2.2. By Application (Coronary Artery Bypass (CABG), Congenital Heart Defect Surgeries, Atrial fibrillation surgery, Others)
  • 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centres, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Beating Heart Stabilizers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Beating Heart Stabilizers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End user
  • 6.3.2. Mexico Beating Heart Stabilizers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End user
  • 6.3.3. Canada Beating Heart Stabilizers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End user

7. Europe Beating Heart Stabilizers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Beating Heart Stabilizers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End user
  • 7.3.2. Germany Beating Heart Stabilizers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Beating Heart Stabilizers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Beating Heart Stabilizers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Beating Heart Stabilizers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End user

8. Asia-Pacific Beating Heart Stabilizers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Beating Heart Stabilizers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End user
  • 8.3.2. India Beating Heart Stabilizers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End user
  • 8.3.3. South Korea Beating Heart Stabilizers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End user
  • 8.3.4. Japan Beating Heart Stabilizers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Beating Heart Stabilizers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End user

9. South America Beating Heart Stabilizers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Beating Heart Stabilizers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End user
  • 9.3.2. Argentina Beating Heart Stabilizers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End user
  • 9.3.3. Colombia Beating Heart Stabilizers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End user

10. Middle East and Africa Beating Heart Stabilizers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Beating Heart Stabilizers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End user
  • 10.3.2. Saudi Arabia Beating Heart Stabilizers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End user
  • 10.3.3. UAE Beating Heart Stabilizers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Terumo Cardiovascular Systems Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic PLC
• 15.3. Visionary Medtech Solutions Pvt. Ltd.
• 15.4. Getinge AB
• 15.5. LivaNova PLC
• 15.6. Guidant Corporation
• 15.7. HTKD Medical.
• 15.8. Chase Medical
• 15.9. Edwards Lifesciences Corporation
• 15.10. Atricure, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer